Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Account Payables: 2020-2025

Historic Change in Account Payables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$2.9 million.

  • Maravai Lifesciences Holdings' Change in Account Payables fell 20.08% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $422,000, marking a year-over-year increase of 229.69%. This contributed to the annual value of $723,000 for FY2024, which is 86.32% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Change in Account Payables stood at -$2.9 million for Q3 2025, which was down 263.08% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Account Payables registered a high of $4.6 million during Q2 2024, and its lowest value of -$4.4 million during Q3 2022.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Change in Account Payables value was $1.7 million (recorded in 2023), while the average stood at $379,545.
  • In the last 5 years, Maravai Lifesciences Holdings' Change in Account Payables spiked by 13,223.53% in 2021 and then plummeted by 1,466.81% in 2024.
  • Maravai Lifesciences Holdings' Change in Account Payables (Quarterly) stood at -$867,000 in 2021, then slumped by 300.00% to -$3.5 million in 2022, then surged by 147.84% to $1.7 million in 2023, then spiked by 35.86% to $2.3 million in 2024, then fell by 20.08% to -$2.9 million in 2025.
  • Its Change in Account Payables stands at -$2.9 million for Q3 2025, versus $1.8 million for Q2 2025 and -$708,000 for Q1 2025.